Cargando…

Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection

PURPOSE: Extended liver resection may provide long-term survival in selected patients with Bismuth type IV hilar cholangiocarcinoma (HCCA). The purpose of this study was to identify anatomical factors that predict curative-intended resection. METHODS: Thirty-three of 159 patients with Bismuth type I...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, In Woong, Jang, Jin-Young, Kang, Mee Joo, Kwon, Wooil, Park, Jae Woo, Chang, Ye Rim, Kim, Sun-Whe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127903/
https://www.ncbi.nlm.nih.gov/pubmed/25114888
http://dx.doi.org/10.4174/astr.2014.87.2.87
_version_ 1782330080703283200
author Han, In Woong
Jang, Jin-Young
Kang, Mee Joo
Kwon, Wooil
Park, Jae Woo
Chang, Ye Rim
Kim, Sun-Whe
author_facet Han, In Woong
Jang, Jin-Young
Kang, Mee Joo
Kwon, Wooil
Park, Jae Woo
Chang, Ye Rim
Kim, Sun-Whe
author_sort Han, In Woong
collection PubMed
description PURPOSE: Extended liver resection may provide long-term survival in selected patients with Bismuth type IV hilar cholangiocarcinoma (HCCA). The purpose of this study was to identify anatomical factors that predict curative-intended resection. METHODS: Thirty-three of 159 patients with Bismuth type IV HCCA underwent major hepato-biliary resection with curative intent (CIR) between 2000 and 2010. Disease extent and anatomical variations were analyzed as factors enabling CIR. RESULTS: CIR ratio with hilar trifurcation bile duct variation (13/16) was significantly higher than that with other bile duct variation types (18/25). Hilum to left second bile duct confluence and tumor infiltration over left second bile duct confluence lengths in right-sided CIR were significantly shorter than those lengths in left-sided CIR (10.8 ± 4.9 and 2.7 ± 0.8 mm vs. 16.5 ± 8.4 and 7.0 ± 5.3 mm, respectively). Left-sided CIR patients had a marginally higher proportion of tumors invading ≤5 mm over the right second confluence than that in right-sided CIR patients (13/17 vs. 6/16; P = 0.061). The 3-year survival rate after CIR (28%) was significantly higher than after non-CIR (6.1%). CONCLUSION: We recommend the criteria of CIR as bile duct variation type, length of hilum to contralateral second bile duct confluence, and extent of tumor infiltration over the second confluence for Bismuth type IV HCCA.
format Online
Article
Text
id pubmed-4127903
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Surgical Society
record_format MEDLINE/PubMed
spelling pubmed-41279032014-08-11 Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection Han, In Woong Jang, Jin-Young Kang, Mee Joo Kwon, Wooil Park, Jae Woo Chang, Ye Rim Kim, Sun-Whe Ann Surg Treat Res Original Article PURPOSE: Extended liver resection may provide long-term survival in selected patients with Bismuth type IV hilar cholangiocarcinoma (HCCA). The purpose of this study was to identify anatomical factors that predict curative-intended resection. METHODS: Thirty-three of 159 patients with Bismuth type IV HCCA underwent major hepato-biliary resection with curative intent (CIR) between 2000 and 2010. Disease extent and anatomical variations were analyzed as factors enabling CIR. RESULTS: CIR ratio with hilar trifurcation bile duct variation (13/16) was significantly higher than that with other bile duct variation types (18/25). Hilum to left second bile duct confluence and tumor infiltration over left second bile duct confluence lengths in right-sided CIR were significantly shorter than those lengths in left-sided CIR (10.8 ± 4.9 and 2.7 ± 0.8 mm vs. 16.5 ± 8.4 and 7.0 ± 5.3 mm, respectively). Left-sided CIR patients had a marginally higher proportion of tumors invading ≤5 mm over the right second confluence than that in right-sided CIR patients (13/17 vs. 6/16; P = 0.061). The 3-year survival rate after CIR (28%) was significantly higher than after non-CIR (6.1%). CONCLUSION: We recommend the criteria of CIR as bile duct variation type, length of hilum to contralateral second bile duct confluence, and extent of tumor infiltration over the second confluence for Bismuth type IV HCCA. The Korean Surgical Society 2014-08 2014-07-29 /pmc/articles/PMC4127903/ /pubmed/25114888 http://dx.doi.org/10.4174/astr.2014.87.2.87 Text en Copyright © 2014, the Korean Surgical Society http://creativecommons.org/licenses/by-nc/3.0/ Annals of Surgical Treatment and Research is an Open Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Han, In Woong
Jang, Jin-Young
Kang, Mee Joo
Kwon, Wooil
Park, Jae Woo
Chang, Ye Rim
Kim, Sun-Whe
Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection
title Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection
title_full Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection
title_fullStr Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection
title_full_unstemmed Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection
title_short Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection
title_sort role of resection for bismuth type iv hilar cholangiocarcinoma and analysis of determining factors for curative resection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127903/
https://www.ncbi.nlm.nih.gov/pubmed/25114888
http://dx.doi.org/10.4174/astr.2014.87.2.87
work_keys_str_mv AT haninwoong roleofresectionforbismuthtypeivhilarcholangiocarcinomaandanalysisofdeterminingfactorsforcurativeresection
AT jangjinyoung roleofresectionforbismuthtypeivhilarcholangiocarcinomaandanalysisofdeterminingfactorsforcurativeresection
AT kangmeejoo roleofresectionforbismuthtypeivhilarcholangiocarcinomaandanalysisofdeterminingfactorsforcurativeresection
AT kwonwooil roleofresectionforbismuthtypeivhilarcholangiocarcinomaandanalysisofdeterminingfactorsforcurativeresection
AT parkjaewoo roleofresectionforbismuthtypeivhilarcholangiocarcinomaandanalysisofdeterminingfactorsforcurativeresection
AT changyerim roleofresectionforbismuthtypeivhilarcholangiocarcinomaandanalysisofdeterminingfactorsforcurativeresection
AT kimsunwhe roleofresectionforbismuthtypeivhilarcholangiocarcinomaandanalysisofdeterminingfactorsforcurativeresection